Get the Stockscreener App
0.4537
6.63%
-0.0322
After Hours:
.46
0.0063
+1.39%
Immutep Limited Adr stock is traded at $0.4537, with a volume of 935.06K.
It is down -6.63% in the last 24 hours and down -20.82% over the past month.
Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.
See More
Previous Close:
$0.4859
Open:
$0.4892
24h Volume:
935.06K
Relative Volume:
0.07
Market Cap:
$66.86M
Revenue:
-
Net Income/Loss:
$-54.17M
P/E Ratio:
-1.2265
EPS:
-0.3699
Net Cash Flow:
$-39.34M
1W Performance:
-9.78%
1M Performance:
-20.82%
6M Performance:
-75.99%
1Y Performance:
-76.61%
1-Day Range:
$0.45
$0.4899
1-Week Range:
$0.45
$0.4941
52-Week Range:
$0.2928
$3.5299
Immutep Limited Adr Stock (IMMP) Company Profile
Compare IMMP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMMP
Immutep Limited Adr
|
0.4537 | 71.61M | 0 | -54.17M | -39.34M | -0.3699 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-26 | Downgrade | Citizens | Mkt Outperform → Mkt Perform |
| Mar-13-26 | Downgrade | Maxim Group | Buy → Hold |
| Mar-13-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-17-26 | Initiated | Citizens | Mkt Outperform |
| May-17-24 | Initiated | CapitalOne | Overweight |
| Aug-03-23 | Initiated | Robert W. Baird | Outperform |
| Aug-03-21 | Initiated | Ladenburg Thalmann | Buy |
| Jul-16-21 | Resumed | Maxim Group | Buy |
| Sep-28-18 | Initiated | B. Riley FBR | Buy |
| Feb-15-18 | Reiterated | Maxim Group | Buy |
View All
Immutep Limited Adr Stock (IMMP) Latest News
Bronstein, Gewirtz & Grossman LLC Urges Immutep Limited Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Pomerantz LLP Highlights Legal Filing Against Immutep Limited – IMMP - ACCESS Newswire
symbol__ Stock Quote Price and Forecast - CNN
IMMP Technical Analysis | Trend, Signals & Chart Patterns | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
Pomerantz LLP Highlights Class Action Against Immutep Limited – IMMP - ACCESS Newswire
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - Morningstar
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit - Morningstar
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP - FinancialContent
Pomerantz LLP Calls Attention to Class Action Involving Immutep Limited – IMMP - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming DeadlinesIMMP - ChartMill
IMMP INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - ChartMill
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline - Morningstar
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP - ChartMill
IMMP Shareholder Alert: Immutep Limited Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Morningstar
IMMP Stock Price, Quote & Chart | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
ROSEN, A TOP RANKED LAW FIRM, Encourages Immutep Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Rosen Law Firm Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - Lelezard
Rosen Law Firm Investigates Immutep Securities Fraud Claims - Intellectia AI
IMMP Class Action Reminder - GlobeNewswire Inc.
IMMP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Immutep Limited - Barchart.com
IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 - ChartMill
Rosen Law Firm Urges Immutep Ltd. (NASDAQ: IMMP) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
IMMP Investor News: If You Have Suffered Losses in Immutep - GlobeNewswire
IMMP Forecast, Price Target & Analyst Ratings | IMMUTEP LTD-SP ADR (NASDAQ:IMMP) - ChartMill
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, A LEADING LAW FIRM, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
ROSEN, LEADING INVESTOR COUNSEL, Encourages Immutep Ltd. Investors to Inquire About Securities Class Action InvestigationIMMP - TMX Newsfile
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immutep LimitedIMMP - ChartMill
Immutep LTD ADR (IMMP) News, Articles, Events & Latest Updates - Stocktwits
IMMP Investor Alert: Immutep Ltd. Securities Fraud InvestigationInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Failed To Disclose Material Risks Related To Trial Viability : Levi & Korsinsky - Sahm
Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings - Sahm
Dow Gains 100 Points; Bank of America Earnings Top Views - Sahm
US Market Preview | IMMP Surges 200%; Trump on Iran War: 'Close to Over'; Tesla AI5 Chip Tapped Out; ASML Falls 3% After Weak Q2 Outlook - Sahm
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15% - Investing.com
These stocks are moving in today's session - ChartMill
Which stocks are most active on Wednesday? - ChartMill
Here are the top movers in Wednesday's session. - ChartMill
Immutep Limited Adr Stock (IMMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):